pubmed-article:17960855 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0014442 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C1947933 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0205161 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0683919 | lld:lifeskim |
pubmed-article:17960855 | lifeskim:mentions | umls-concept:C0205547 | lld:lifeskim |
pubmed-article:17960855 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:17960855 | pubmed:dateCreated | 2007-12-24 | lld:pubmed |
pubmed-article:17960855 | pubmed:abstractText | The prevalence of elevated liver enzymes has not been described in patients with atrial fibrillation (AF) who may be more likely to develop these abnormalities due to comorbidities and medications. As signals of liver injury lead to termination of drug development programs, an attempt to better define the background prevalence would aid in interpreting these elevations in the setting of exposure to a new drug. The aim of this study was to estimate the prevalence and incidence of alanine aminotransferase (ALT) elevations in a cohort with AF. | lld:pubmed |
pubmed-article:17960855 | pubmed:language | eng | lld:pubmed |
pubmed-article:17960855 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17960855 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17960855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17960855 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17960855 | pubmed:month | Jan | lld:pubmed |
pubmed-article:17960855 | pubmed:issn | 1053-8569 | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:StaddonS LSL | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:KimmelStephen... | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:YangYu-XiaoYX | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:BurkeAnneA | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:WeinerMark... | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:HanXiaoyanX | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:MakarGeorge... | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:NesselLisaL | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:SellersKimber... | lld:pubmed |
pubmed-article:17960855 | pubmed:author | pubmed-author:BennettDimitr... | lld:pubmed |
pubmed-article:17960855 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17960855 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:17960855 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17960855 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17960855 | pubmed:pagination | 43-51 | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:meshHeading | pubmed-meshheading:17960855... | lld:pubmed |
pubmed-article:17960855 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:17960855 | pubmed:articleTitle | Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. | lld:pubmed |
pubmed-article:17960855 | pubmed:affiliation | Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. george.makar@uphs.upenn.edu | lld:pubmed |
pubmed-article:17960855 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17960855 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |